Skip to content

A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy

Phase 2 Study Evaluation of Topical 10% Metronidazole Ointment for the Reduction of Pain After Haemorrhoidectomy

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00774722
Enrollment
59
Registered
2008-10-17
Start date
2006-09-30
Completion date
2008-03-31
Last updated
2013-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemorrhoidectomy

Brief summary

The purpose of this study is to determine whether metronidazole 10% ointment , applied topically three times a day in and around the anus, on the reduction of pain following haemorrhoidectomy.

Interventions

DRUGMetronidazole

10% ointment, three times daily for 14 days

Sponsors

S.L.A. Pharma AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have Grade 3 or 4 haemorrhoids (external disease with or without significant internal component) * Be scheduled for diathermy haemorroidectomy with ≥2 quadrant involvement * Be medically fit for surgery * Subjects must be aged 18 years or over and of the legal age of consent. * If female, the subject must not be lactating and must be (a) post-menopausal, (b) surgically sterilised, or (c) have a negative pregnancy test result prior to entry into the study and will use adequate contraception for the duration of the study. * Must have provided written informed consent to participate.

Exclusion criteria

* They have had surgery to the anus or rectum in the past 8 weeks * Suffer from a chronic pain syndrome which requires regular narcotic analgesia * Have anal fissures * Have diagnosed Crohn's disease * Allergic to metronidazole * Are taking any prohibited medication. * Deemed mentally incompetent * Considered by their physician unlikely to be able to comply with the protocol. * Taken part in an experimental drug study in the preceding three months.

Design outcomes

Primary

MeasureTime frame
The primary objective is to evaluate the efficacy of 10% metronidazole ointment in reducing post-operative pain associated with haemorrhoidectomy as compared to placebo.14 days

Secondary

MeasureTime frame
evaluate and compare the expected pain following haemorrhoidectomy in the treatment and placebo groups. overall patient satisfaction with the operation. the number of analgesics required post-operatively the time taken to return to work and/or56 days

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026